Metraipolis › archive › dc_8628779da475

Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery — Europe PMC PMID:41875063

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41875063
DOI
10.2478/raon-2026-0014
License (as archived)
solo-consultazione
Archived
2026-11-04T01:30:50.496Z
SHA-256 of the archived text
581e0a8305e4260e847072aeafa5f2d30e6a291733e6c0145e700077c42b11ae
Stable URL of this page
https://metraipolis.com/documento/dc_8628779da475

How to cite

Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery — Europe PMC PMID:41875063 — Europe PMC (en), https://europepmc.org/article/MED/41875063 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8628779da475 (Metraipolis archive dc_8628779da475, sha256 581e0a8305e4260e847072aeafa5f2d30e6a291733e6c0145e700077c42b11ae)
BibTeX
@misc{dc8628779da475,
  title = {Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell Recovery — Europe PMC PMID:41875063},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41875063},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8628779da475; sha256 581e0a8305e4260e847072aeafa5f2d30e6a291733e6c0145e700077c42b11ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41875063. Agents can read the archived copy with the MCP tool read_document.